2024 Post-Election Outlook: Healthcare & Life Sciences

Holland & Knight's experienced attorneys and lobbyists are focusing on the policy implications of the 2024 elections. We look forward to you joining us as members of the firm's Public Policy & Regulation Group and Healthcare & Life Sciences Policy Team discuss the impacts on industry priorities that matter to you.

The election will bring a new administration and Congress with distinct healthcare policy priorities, including significant changes in healthcare committees. Our speakers will analyze the election results, prepare stakeholders for potential policy shifts and discuss the implications for healthcare policy during the lame-duck congressional session and into 2025. This will include a look at the future of the Affordable Care Act and Inflation Reduction Act, the size and role of federal healthcare agencies, as well as Medicaid management and policies, among other key topics.